The stock has gained 2.28 percent in the last one year and 16.7 percent in the last six months

Balaji Amines gains 3% after subsidiary gets mega project status

Intense competition from global players affected margins.

Balaji Amines Q2 Results Review - Significant Decline In Revenue Due To Drop In Price Realisation: KRChoksey

The management is unavailable as they are involved in the company’s subsidiary, Balaji Speciality Chemicals’ proposed IPO.

Balaji Amines Delays Q1 Results Due To Unavailability Of Management

In May, five independent directors decided to step down from their positions, explaining that their departure was driven by personal factors.

Investors dump Balaji Amines after delay in Q1 results; stock falls

Stocks to Watch on Monday, July 3: Post the approval of the merger between HDFC Bank and HDFC, the trading window in HDFC Ltd will remain closed till July 13

Stocks to Watch on July 3: HDFC twins, TMB, auto shares, SBI, Balaji Amines

KR Choksey is bullish on Balaji Amines has recommended buy rating on the stock with a target price of Rs 3191 in its research report dated May 25, 2023.

Buy Balaji Amines; target of Rs 3191: KR Choksey

Key monitorable to watch would be sustenance of operating margins for the subsidiary - Balaji Specialty.

Balaji Amines: Does it merit a look?

Balaji Amines share price: The weakness in the share price came after the company posted a 57.81 per cent decline (year-on-year) in the March 2023 quarter (Q4 FY23). Profit after tax (PAT) for Q4 FY23 was Rs 55.21 crore as compared to Rs 130.85 crore in Q4 FY22. Diluted EPS (earnings per share) for …

Balaji Amines shares cut losses after diving 19% today

#BalajiAmines tanked 15% after its five independent directors & CFO resigned at once.

#GeojitFinancial's Gaurang Shah shares his views on the stock and other stocks buzzing in trade today. #BQLive 

--------------------------------------------------------------------------------------------------------------------
For more videos subscribe to our channel: http://bit.ly/32JXa74
Visit BQ Prime for more news: https://www.bqprime.com/
Don't enter the stock market unaware. Read all Research Reports here: https://www.bqprime.com/research-reports

For the latest business news and analysis
Subscribe to our Newsletters here: https://www.bqprime.com/my-bq/newsletter
Subscribe to our Telegram channel: https://t.me/BQPrime

Follow BQ Prime here
Twitter: https://twitter.com/bqprime
Facebook: https://www.facebook.com/BQPrime/
LinkedIn: https://www.linkedin.com/company/13184554/
Instagram: https://www.instagram.com/bqprime/
Pinterest: https://in.pinterest.com/BQPrimeNews/

Stocks In Focus | NTPC, JSW Steel, Glenmark Pharma, Balaji Amines and more | BQ Prime

Balaji Amines’ Q4 numbers disappointed the Streets on the all three fronts of profit, revenue and profitability.

Dismal Q4 earnings drag Balaji Amines shares to 52-week low

Hemanth Reddy Gaddam has also resigned as whole-time director & CFO of the company with effect from closing hours on May 2023 to focus on its subsidiary Balaji Speciality Chemicals

Balaji Amines tanks 19%, hits 52-week low on weak Q4 results

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Balaji Amines Limited is a company, which is engaged in the manufacturing of Aliphatic Amines, their derivatives and specialty chemicals. The Company is running a five star hotel, Balaji Sarovar Premiere.